West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
248.06
+2.20 (0.89%)
At close: Mar 9, 2026, 4:00 PM EDT
248.06
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:40 PM EDT
WST Revenue
In the year 2025, West Pharmaceutical Services had annual revenue of $3.07B with 6.25% growth. West Pharmaceutical Services had revenue of $805.00M in the quarter ending December 31, 2025, with 7.51% growth.
Revenue (ttm)
$3.07B
Revenue Growth
+6.25%
P/S Ratio
5.72
Revenue / Employee
$284,639
Employees
10,800
Market Cap
17.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.07B | 180.90M | 6.25% |
| Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
| Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
| Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
| Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Becton, Dickinson and Company | 21.92B |
| Baxter International | 11.24B |
| Alcon | 10.40B |
| Solventum | 8.33B |
| ResMed | 5.40B |
| Bausch + Lomb | 5.10B |
| The Cooper Companies | 4.15B |
| Hologic | 4.13B |
WST News
- 47 minutes ago - Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc. - PRNewsWire
- 10 days ago - Best Dividend Aristocrats For March 2026 - Seeking Alpha
- 10 days ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 20 days ago - West Announces Quarterly Dividend and Share Repurchase Program - PRNewsWire
- 25 days ago - West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - West Pharma forecasts 2026 profit above estimates on strong demand for drug components - Reuters
- 25 days ago - West Reports Fourth-Quarter and Full-Year 2025 Results - PRNewsWire
- 4 weeks ago - West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript - Seeking Alpha